-- (更新价格。) 周四午后,由于市场乐观预期结束伊朗战争的协议可能即将达成,金价连续第三个交易日上涨,导致油价下跌,美元走低。此前,市场对战争引发的供应冲击将推高通胀并迫使利率上升的担忧有所缓解。 6月交割的黄金期货价格上涨20.60美元,至每盎司4,714.00美元,此前周三已上涨125.80美元。 此次上涨源于市场对美国和伊朗达成和平协议的乐观预期。《华尔街日报》报道称,两国正在与调解人合作,制定重启谈判的框架。双方最早将于下周在巴基斯坦就特朗普政府提出的14点谅解备忘录展开会谈。 在伊朗封锁霍尔木兹海峡引发的经济动荡期间,交易员们对将黄金作为避险资产持谨慎态度。此次封锁切断了波斯湾国家的石油出口,而这些国家供应了全球20%的石油需求。2月28日战争爆发后,油价高企,推高了通胀,加剧了人们对各国央行将提高利率以抑制需求的担忧。不过,有关可能结束敌对行动的谈判前景缓解了这种担忧。 加拿大皇家银行资本市场(RBC Capital Markets)黄金和天然气策略师克里斯托弗·卢尼(Christopher Louney)写道:“昨天黄金对停火乐观情绪的反应,强化了我们对黄金基本面依然稳固的看法,并增强了我们长期以来对今年黄金价格将在每盎司4500-5000美元区间波动的信心。” 美元小幅走高,ICE美元指数上涨0.0点至98.11。美国国债收益率上升,两年期国债收益率最新上涨 4.9 个基点至 3.919%,十年期国债收益率上涨 4.2 个基点至 4.393%。
Related Articles
Sector Update: Consumer Stocks Edge Lower Late Afternoon
Consumer stocks were edging down late Thursday afternoon, with the State Street Consumer Staples Select Sector SPDR ETF (XLP) and the State Street Consumer Discretionary Select Sector SPDR ETF (XLY) each decreasing 0.1%.In corporate news, Tapestry (TPR) raised its fiscal 2026 outlook after delivering a Q3 beat, but provided a subdued Q4 sales guidance for its Kate Spade brand. Its shares dropped more than 13%.Shake Shack (SHAK) shares slumped 28% after the company's Q1 results missed Wall Street estimates.Planet Fitness (PLNT) shares tumbled 32% after the company tempered its full-year outlook amid fewer-than-expected member additions in Q1.McDonald's (MCD) reported better-than-expected Q1 results as comparable sales rebounded more than market estimates despite what the company described as a "challenging" environment. Its shares rose 0.3%.
Sector Update: Health Care Stocks Softer Late Afternoon
Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index decreasing 0.6% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.7%.The iShares Biotechnology ETF (IBB) dropped 2.2%.In corporate news, Entrada Therapeutics (TRDA) shares tumbled 57% after its drug for children with Duchenne muscular dystrophy fell short of analyst expectations in an early-to-mid stage trial, Reuters reported Thursday.Iovance Biotherapeutics (IOVA) shares fell past 13% after the company's Q1 loss narrowed less than expected and revenue missed estimates.Harmony Biosciences (HRMY) shares dropped 5.5% after the company's Q1 earnings and revenue fell short of analysts' estimates.Catalyst Pharmaceuticals (CPRX) shares rose 2.1% after the company agreed to be acquired by Angelini Pharma in a deal with an equity value of about $4.1 billion. The company also said it has reached a settlement agreement with Hetero Labs to resolve patent litigation regarding a proposed generic version of Firdapse.
Cascades Target Eased To C$13 From $14, Keeps Sector Perform at National Bk Which Notes Q1 In Line With Reduced Outlook, Soft Q2 Outlook Before Recovery, Asset Sales Done By Q3
Price: $10.72, Change: $-0.23, Percent Change: -2.10%